4.5 Article

Role of respiratory syncytial virus in acute otitis media: Implications for vaccine development

Journal

VACCINE
Volume 25, Issue 9, Pages 1683-1689

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2006.10.045

Keywords

otitis media; respiratory syncytial virus; vaccine

Funding

  1. NIDCD NIH HHS [R01 DC005841, R01 DC5841, R01 DC2620] Funding Source: Medline

Ask authors/readers for more resources

We summarize herein the results of various virologic studies of acute otitis media (AOM) conducted at our site over a 10-year period. Among 566 children with AOM, respiratory syncytial virus (RSV) was the most common virus identified in either middle ear fluid or nasal wash it was found in 16% of all children and 38% of virus-positive children. Seventy-one percent of the children with RSV were I year of age or older, which was significantly older than all other viruses combined (P = 0.045). RSV infection was associated with the common bacterial pathogens causing AOM. Past efforts to develop vaccines for RSV have emphasized prevention of lower respiratory tract infection in infants, which is a more serious problem but less common than AOM. Our results Suggest that RSV vaccines that work only against infection in older children may have value in preventing AOM, the most common pediatric disease. (c) 2006 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available